NDLI: Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case–control study 1988

Content Provider	Springer Nature Link
Author	Wagner, Philippe Alvegård, Thor Ranstam, Jonas Rydholm, Anders Vult von Steyern, Fredrik Olsson, Håkan
Copyright Year	2014
Abstract	The study was designed to investigate the influence of surrogate factors associated with sex (SH) and growth hormones (GH) on the risk of developing soft tissue sarcomas (STS).The etiology of soft tissue sarcoma is largely unknown. We have studied the effect of hormone related factors on STS in the Swedish population between 1988 and 2009 using a population-based matched case–control design.Our study is the largest on this topic to date, including 634 cases in a primary matched analysis and 855 cases in an unmatched sensitivity analysis. We identified protective effects connected to constitutional characteristics, hormonal and reproductive factors. Being shorter than your peers at age 11 was associated with an odds ratio (OR) of 0.51 (0.36–0.74). Having used oral contraceptives (OC), OR 0.75 (0.49–1.15), and high parity, OR 0.16 (0.04–0.63), comparing three or more children to two or less, also appeared to reduce the risk of STS. The risk was further reduced with the duration of OC use (p = 0.01), comparing use for 11 years or more to use for 3 years or less yielded an OR of 0.10 (0.02–0.41). No effect was observed for ever having had perimenopausal hormone therapy OR 1.02 (0.70–1.47). The effect of BMI varied significantly with subtype (p = 0.03) and tumor location (p < 0.001).We observed surrogates of SH, GH, and insulin-like growth factor 1 to be associated with STS development. These findings are important as they may connect STSs to the group of hormone-dependent tumors, potentially revealing common treatment and prevention targets.
Starting Page	1167
Ending Page	1177
Page Count	11
File Format	PDF
ISSN	09575243
Journal	Cancer Causes & Control
Volume Number	25
Issue Number	9
e-ISSN	15737225
Language	English
Publisher	Springer International Publishing
Publisher Date	2014-07-18
Publisher Place	Cham
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Soft tissue sarcoma Oral contraceptives Parity Stature IGF-1 Sex hormones Cancer Research Biomedicine general Oncology Public Health Epidemiology Hematology
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

A prospective study of oral contraceptive use and colorectal adenomas

Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer

Oral contraceptive use and risk of breast carcinoma in situ (United States)

A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964

Exogenous sex hormone use and risk of meningioma: a population-based case–control study in Finland

Risk of breast cancer associated with short-term use of oral contraceptives

Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children’s Oncology Group

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women

Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case–control study 1988–2009

Similar Documents

A prospective study of oral contraceptive use and colorectal adenomas

Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer

Oral contraceptive use and risk of breast carcinoma in situ (United States)

A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964

Exogenous sex hormone use and risk of meningioma: a population-based case–control study in Finland

Risk of breast cancer associated with short-term use of oral contraceptives

Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children’s Oncology Group

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women

Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case–control study 1988–2009